Founded in 1986, Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin at Pondicherry. Over the years, Aurobindo has expanded its product portfolio to include formulations in various therapeutic areas such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology, and antibiotics. With a strong R&D focus, the company operates 29 manufacturing and packaging facilities worldwide, approved by leading regulatory agencies including USFDA, UK MHRA, and WHO. Aurobindo's mission is to become the most valued pharma partner by continuously researching, developing, and manufacturing a wide range of pharmaceutical products that comply with the highest regulatory standards.